SlideShare a Scribd company logo
1 of 79
Dr. Nagula Praveen, MD, DM
Assistant Professor of Cardiology,
Osmania General Hospital,
Hyderabad
drpraveennagula@gmail.com
twitter: @kizashipraveen
Agenda
īąIntroduction
īąCOVID pandemic
īąManagement of CVD
īąPrevention
COronaVIrusDisease 2019 (COVID)
Closely related to SARS
NOVEL CORONA VIRUS
Corona virus family
ī‚§ Latin for crown, greek for garland
ī‚§ Enveloped, positive sense, single stranded RNA viruses
ī‚§ Peplomers or spikes on the surface
ī‚§ Usually mild infections – common cold
ī‚§ SARS, MERS, COVID 19 – lethal
Indian Perspective
Why CVD to be worried in COVID
times?
10.8% IN MORTALITY (3.4% USUALLY)
ī‚§ Both have similar symptoms
ī‚§ CV diseases usually are emergencies when presented to ED
ī‚§ Appropriate effective timely management is important to combat the
consequences if not treated (TIME IS MUSCLE, TIME IS LIFE)
ī‚§ HCP and patients are at risk of COVID
ī‚§ CVD and its risk factors – complications are more
ī‚§ All CV Patients to be deemed to be positive for COVID and managed.
Issues
Patient aspects
ī‚§ Fear of COVID infection
ī‚§ Unable to meet the expenses of admission
ī‚§ Neglecting the symptoms, in background of COVID fear
ī‚§ Denied access in absence of report - alarm raised
ī‚§ Loss of daily wages
ī‚§ Poverty
HCP Aspects
ī‚§ Patient to be treated on an emergency basis.
ī‚§ Aerosol production can be there when doing procedures – more
precautions
ī‚§ Limited personnel at hand in view of social distancing.
ī‚§ Lot of stress in managing the patients
ī‚§ Primary PCI < Pharmacoinvasive strategy
ī‚§ Donning and doffing strict precautions to be taken - 30 minutes
ī‚§ Not 100% effective ( usually when not followed the steps)
ī‚§ Takes ten to fifteen minutes to donn/doff
ī‚§ Cumbersome after an hour
ī‚§ Cant move around
ī‚§ Mind is not stable
ī‚§ Procedure time delayed
ī‚§ Touch sensation lost
HOSPITAL aspects
ī‚§ Increased staff
ī‚§ 1:1 ratio of nurse to patients
ī‚§ Use of PPE Kits
ī‚§ Shortage of HCP
ī‚§ Decontamination
ī‚§ Three times the usual expenses
ī‚§ Shortage of PPE kits
ī‚§ Salaries ?
ī‚§ Disposables
ī‚§ Sterilization
ī‚§ Expenses
ESC guidance (not guidelines, not consensus)
Triaging of patients is important
STEMI
ī‚§ Pharmacoinvasive strategy is better than Primary PCI.
ī‚§ It is evidence based
ī‚§ STREAM Trial ( fibrinolytic therapy vs PPCI)
ī‚§ MORTALITY < 5%
ī‚§ Increased ICH in FT
ī‚§ Beneficial in Present times
ī‚§ TIME OF REPERFUSION is MORE IMPORTANT THAN MODE OF
REPERFUSION
PUI = person under investigation
PI = pharmacoinvasive strategy;
ICU admission
NSTEMI
Acute Heart Failure
ī‚§ Acute myocardial injury (defined as serum hs-cTn I elevation > 99th percentile of the
ULN or new abnormalities in ECG or echocardiography) occurs in 8% of COVID-19
patients.
ī‚§ Ischemia, Infarction, Inflammation (Myocarditis)
ī‚§ Severe COVID 22-31%
ī‚§ Higher troponin values more poor prognosis
ī‚§ Elevate NT BNP
ī‚§ ARDS, Hypoxia, Acute Kidney Injury, hypervolemia, stress induced cardiomyopathy
ī‚§ Arrhythmias
Cardiogenic
Shock
Chronic Heart Failure
ī‚§ Risk of COVID is higher
ī‚§ TTE and chest CT scan can be used for further assessment.
ī‚§ Attention should be given to the prevention of viral transmission to healthcare providers and
contamination of the equipment;
ī‚§ Patients with chronic HF should closely follow protective measures to prevent infection;
ī‚§ Ambulatory stable HF patients (with no cardiac emergencies) should refrain from hospital
visits;
ī‚§ Guideline-directed medical therapy (including beta-blocker, ACEI, ARB or sacubitril/valsartan
and mineralocorticoid receptor antagonist), should be continued in chronic HF patients,
irrespective of COVID-19;
ī‚§ Telemedicine should be considered whenever possible to provide medical advice and follow
up of stable HF patients.
CSA
arrhythmias
QT management
Hypertension
Interaction of drugs
NATURE CURES ITSELF
COVID IS NO EXCEPTION
But after every eclipse
there is sunshine
FAKE NEWS
SOCIAL MEDIA
Take Home Message
ī‚§ All patients with CVD are at high risk of severeCOVID.
ī‚§ COVID mimics CVD – similar symptoms
ī‚§ Type 2 MI
ī‚§ All patients requiring emergency care should be deemed as COVID positive.
ī‚§ Pharmacoinvasive therapy is better than Primary PCI
ī‚§ Elective procedures to be avoided
ī‚§ Telemedicine to be encouraged for effective bonding with patients.
ī‚§ Patient should restrict to home and access hospital only in an emergency
ī‚§ Follow SMS.
(Acute) Cardiac Care in COVID era
(Acute) Cardiac Care in COVID era

More Related Content

What's hot

Post covid pulmonary fibrosis , atypical covid19 sequele
Post covid pulmonary fibrosis , atypical covid19 sequelePost covid pulmonary fibrosis , atypical covid19 sequele
Post covid pulmonary fibrosis , atypical covid19 sequeleDr-Ajay Tripathi
 
COVID 19 and The Heart - Lessons Learnt from this Pandemic
COVID 19 and The Heart - Lessons Learnt from this PandemicCOVID 19 and The Heart - Lessons Learnt from this Pandemic
COVID 19 and The Heart - Lessons Learnt from this Pandemicahvc0858
 
Clinical Management of COVID-19 (SARS-Cov-2) Patients
Clinical Management of COVID-19 (SARS-Cov-2) PatientsClinical Management of COVID-19 (SARS-Cov-2) Patients
Clinical Management of COVID-19 (SARS-Cov-2) PatientsEmad Qasem
 
Covid-19 :Cardiovascular considerations
Covid-19 :Cardiovascular considerationsCovid-19 :Cardiovascular considerations
Covid-19 :Cardiovascular considerationsDr.Mahmoud Abbas
 
Managing comorbidities in heart failure
Managing comorbidities in heart failureManaging comorbidities in heart failure
Managing comorbidities in heart failureashwani mehta
 
Covid 19 & Hypercoagulability
Covid 19 & HypercoagulabilityCovid 19 & Hypercoagulability
Covid 19 & HypercoagulabilityMonkez M Yousif
 
Evaluation of Cardiac Complications in Pateint Undergoing COVID 19 Treatment:...
Evaluation of Cardiac Complications in Pateint Undergoing COVID 19 Treatment:...Evaluation of Cardiac Complications in Pateint Undergoing COVID 19 Treatment:...
Evaluation of Cardiac Complications in Pateint Undergoing COVID 19 Treatment:...DrHeena tiwari
 
How to differentiate covid 19 pneumonia from heart failure by ct
How to differentiate covid 19 pneumonia from heart failure by ctHow to differentiate covid 19 pneumonia from heart failure by ct
How to differentiate covid 19 pneumonia from heart failure by ctDouble M
 
Webinar covid 19pdf
Webinar covid  19pdfWebinar covid  19pdf
Webinar covid 19pdfuzmajoyia
 
Post covid sequle
Post covid sequlePost covid sequle
Post covid sequleTarekHamdy17
 
Post covid anticoagulant role
Post covid anticoagulant rolePost covid anticoagulant role
Post covid anticoagulant roleTarekHamdy17
 
Covid 19 and CHD
Covid 19 and CHDCovid 19 and CHD
Covid 19 and CHDDina Mostafa
 
Covid 19 management 6 months later
Covid 19 management 6 months laterCovid 19 management 6 months later
Covid 19 management 6 months laterWaheed Shouman
 
Post covid effects
Post covid effectsPost covid effects
Post covid effectsfalgunijoshi5
 
Anticoagulation in COVID-19
Anticoagulation in COVID-19Anticoagulation in COVID-19
Anticoagulation in COVID-19Khaled Taema
 

What's hot (20)

Takotsubo y covid
Takotsubo y covidTakotsubo y covid
Takotsubo y covid
 
Post covid pulmonary fibrosis , atypical covid19 sequele
Post covid pulmonary fibrosis , atypical covid19 sequelePost covid pulmonary fibrosis , atypical covid19 sequele
Post covid pulmonary fibrosis , atypical covid19 sequele
 
Controversies in the management of COVID-19
Controversies  in the management of COVID-19Controversies  in the management of COVID-19
Controversies in the management of COVID-19
 
COVID 19 and The Heart - Lessons Learnt from this Pandemic
COVID 19 and The Heart - Lessons Learnt from this PandemicCOVID 19 and The Heart - Lessons Learnt from this Pandemic
COVID 19 and The Heart - Lessons Learnt from this Pandemic
 
Clinical Management of COVID-19 (SARS-Cov-2) Patients
Clinical Management of COVID-19 (SARS-Cov-2) PatientsClinical Management of COVID-19 (SARS-Cov-2) Patients
Clinical Management of COVID-19 (SARS-Cov-2) Patients
 
Covid-19 :Cardiovascular considerations
Covid-19 :Cardiovascular considerationsCovid-19 :Cardiovascular considerations
Covid-19 :Cardiovascular considerations
 
Corona and Heart
Corona and Heart Corona and Heart
Corona and Heart
 
Managing comorbidities in heart failure
Managing comorbidities in heart failureManaging comorbidities in heart failure
Managing comorbidities in heart failure
 
Covid 19 & Hypercoagulability
Covid 19 & HypercoagulabilityCovid 19 & Hypercoagulability
Covid 19 & Hypercoagulability
 
Evaluation of Cardiac Complications in Pateint Undergoing COVID 19 Treatment:...
Evaluation of Cardiac Complications in Pateint Undergoing COVID 19 Treatment:...Evaluation of Cardiac Complications in Pateint Undergoing COVID 19 Treatment:...
Evaluation of Cardiac Complications in Pateint Undergoing COVID 19 Treatment:...
 
How to differentiate covid 19 pneumonia from heart failure by ct
How to differentiate covid 19 pneumonia from heart failure by ctHow to differentiate covid 19 pneumonia from heart failure by ct
How to differentiate covid 19 pneumonia from heart failure by ct
 
Webinar covid 19pdf
Webinar covid  19pdfWebinar covid  19pdf
Webinar covid 19pdf
 
Post covid sequle
Post covid sequlePost covid sequle
Post covid sequle
 
Department of cardiology
Department of cardiologyDepartment of cardiology
Department of cardiology
 
9 x miocarditis fulminante covid
9 x miocarditis fulminante covid9 x miocarditis fulminante covid
9 x miocarditis fulminante covid
 
Post covid anticoagulant role
Post covid anticoagulant rolePost covid anticoagulant role
Post covid anticoagulant role
 
Covid 19 and CHD
Covid 19 and CHDCovid 19 and CHD
Covid 19 and CHD
 
Covid 19 management 6 months later
Covid 19 management 6 months laterCovid 19 management 6 months later
Covid 19 management 6 months later
 
Post covid effects
Post covid effectsPost covid effects
Post covid effects
 
Anticoagulation in COVID-19
Anticoagulation in COVID-19Anticoagulation in COVID-19
Anticoagulation in COVID-19
 

Similar to (Acute) Cardiac Care in COVID era

02.02 adult art initiation gsn
02.02 adult  art initiation gsn02.02 adult  art initiation gsn
02.02 adult art initiation gsnDavid Ngogoyo
 
03.02 management of patients on antiretroviral drugs initiat
03.02 management of patients on antiretroviral drugs initiat03.02 management of patients on antiretroviral drugs initiat
03.02 management of patients on antiretroviral drugs initiatDavid Ngogoyo
 
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MDdrabhishekbabbu
 
Module 3 opportunistic infections and hiv related conditi
Module 3  opportunistic infections and hiv  related  conditiModule 3  opportunistic infections and hiv  related  conditi
Module 3 opportunistic infections and hiv related conditiDavid Ngogoyo
 
Prevention of ARF RHD (recording) (1).pptx
Prevention of ARF  RHD (recording) (1).pptxPrevention of ARF  RHD (recording) (1).pptx
Prevention of ARF RHD (recording) (1).pptxDanaiChiwara
 
Patient safety During Anesthesia
Patient safety During AnesthesiaPatient safety During Anesthesia
Patient safety During Anesthesiaisakakinada
 
H1 N1 Management
H1 N1 ManagementH1 N1 Management
H1 N1 ManagementGamal Agmy
 
The art of the possible ideas
The art of the possible   ideasThe art of the possible   ideas
The art of the possible ideashowardcooper
 
Current Indian Guidelines for Antiretriviral Therapy 2012
Current Indian Guidelines for Antiretriviral Therapy 2012Current Indian Guidelines for Antiretriviral Therapy 2012
Current Indian Guidelines for Antiretriviral Therapy 2012Lakshya K Solanki
 
Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC: ...
Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC: ...Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC: ...
Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC: ...PVI, PeerView Institute for Medical Education
 
haart-170422040325.pdf
haart-170422040325.pdfhaart-170422040325.pdf
haart-170422040325.pdfFadilaLawal
 
haart-170422040325.pdf
haart-170422040325.pdfhaart-170422040325.pdf
haart-170422040325.pdfFadilaLawal
 
Highly active antiretroviral therapy
Highly active antiretroviral therapyHighly active antiretroviral therapy
Highly active antiretroviral therapyAbhishek Gupta
 
Anaesthetic considerations in AIDS.pptx
Anaesthetic considerations in AIDS.pptxAnaesthetic considerations in AIDS.pptx
Anaesthetic considerations in AIDS.pptxSabariKreeshanMariap
 
icu-doing-more-can-be-worse-.pdf
icu-doing-more-can-be-worse-.pdficu-doing-more-can-be-worse-.pdf
icu-doing-more-can-be-worse-.pdfekramy abdo
 
Management of opportunistic diseases
Management of opportunistic diseasesManagement of opportunistic diseases
Management of opportunistic diseasesmikru taye
 
COVID-19 Pneumonia in a Congenital Adrenal Hyperplasia; A Case Report
COVID-19 Pneumonia in a Congenital Adrenal Hyperplasia; A Case ReportCOVID-19 Pneumonia in a Congenital Adrenal Hyperplasia; A Case Report
COVID-19 Pneumonia in a Congenital Adrenal Hyperplasia; A Case Reportsemualkaira
 
COVID-19 pneumonia in a congenital adrenal hyperplasia; a case report
COVID-19 pneumonia in a congenital adrenal hyperplasia; a case reportCOVID-19 pneumonia in a congenital adrenal hyperplasia; a case report
COVID-19 pneumonia in a congenital adrenal hyperplasia; a case reportkomalicarol
 

Similar to (Acute) Cardiac Care in COVID era (20)

02.02 adult art initiation gsn
02.02 adult  art initiation gsn02.02 adult  art initiation gsn
02.02 adult art initiation gsn
 
03.02 management of patients on antiretroviral drugs initiat
03.02 management of patients on antiretroviral drugs initiat03.02 management of patients on antiretroviral drugs initiat
03.02 management of patients on antiretroviral drugs initiat
 
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
 
Module 3 opportunistic infections and hiv related conditi
Module 3  opportunistic infections and hiv  related  conditiModule 3  opportunistic infections and hiv  related  conditi
Module 3 opportunistic infections and hiv related conditi
 
Prevention of ARF RHD (recording) (1).pptx
Prevention of ARF  RHD (recording) (1).pptxPrevention of ARF  RHD (recording) (1).pptx
Prevention of ARF RHD (recording) (1).pptx
 
Patient safety During Anesthesia
Patient safety During AnesthesiaPatient safety During Anesthesia
Patient safety During Anesthesia
 
H1 N1 Management
H1 N1 ManagementH1 N1 Management
H1 N1 Management
 
HIV Aids.pptx
HIV Aids.pptxHIV Aids.pptx
HIV Aids.pptx
 
The art of the possible ideas
The art of the possible   ideasThe art of the possible   ideas
The art of the possible ideas
 
Current Indian Guidelines for Antiretriviral Therapy 2012
Current Indian Guidelines for Antiretriviral Therapy 2012Current Indian Guidelines for Antiretriviral Therapy 2012
Current Indian Guidelines for Antiretriviral Therapy 2012
 
Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC: ...
Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC: ...Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC: ...
Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC: ...
 
haart-170422040325.pdf
haart-170422040325.pdfhaart-170422040325.pdf
haart-170422040325.pdf
 
haart-170422040325.pdf
haart-170422040325.pdfhaart-170422040325.pdf
haart-170422040325.pdf
 
Highly active antiretroviral therapy
Highly active antiretroviral therapyHighly active antiretroviral therapy
Highly active antiretroviral therapy
 
Anaesthetic considerations in AIDS.pptx
Anaesthetic considerations in AIDS.pptxAnaesthetic considerations in AIDS.pptx
Anaesthetic considerations in AIDS.pptx
 
icu-doing-more-can-be-worse-.pdf
icu-doing-more-can-be-worse-.pdficu-doing-more-can-be-worse-.pdf
icu-doing-more-can-be-worse-.pdf
 
Management of opportunistic diseases
Management of opportunistic diseasesManagement of opportunistic diseases
Management of opportunistic diseases
 
COVID-19 Pneumonia in a Congenital Adrenal Hyperplasia; A Case Report
COVID-19 Pneumonia in a Congenital Adrenal Hyperplasia; A Case ReportCOVID-19 Pneumonia in a Congenital Adrenal Hyperplasia; A Case Report
COVID-19 Pneumonia in a Congenital Adrenal Hyperplasia; A Case Report
 
COVID-19 pneumonia in a congenital adrenal hyperplasia; a case report
COVID-19 pneumonia in a congenital adrenal hyperplasia; a case reportCOVID-19 pneumonia in a congenital adrenal hyperplasia; a case report
COVID-19 pneumonia in a congenital adrenal hyperplasia; a case report
 
Prophylaxis and treatment of opportunistic infections in HIV patients - Toxop...
Prophylaxis and treatment of opportunistic infections in HIV patients - Toxop...Prophylaxis and treatment of opportunistic infections in HIV patients - Toxop...
Prophylaxis and treatment of opportunistic infections in HIV patients - Toxop...
 

More from Praveen Nagula

BIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptxBIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptxPraveen Nagula
 
historical aspects of hypertension.pptx
historical aspects of hypertension.pptxhistorical aspects of hypertension.pptx
historical aspects of hypertension.pptxPraveen Nagula
 
Management of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxManagement of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxPraveen Nagula
 
ECGs in clinical practice.pptx
ECGs in clinical practice.pptxECGs in clinical practice.pptx
ECGs in clinical practice.pptxPraveen Nagula
 
PCP IN STEMI.pptx
PCP IN STEMI.pptxPCP IN STEMI.pptx
PCP IN STEMI.pptxPraveen Nagula
 
HISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSIONHISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSIONPraveen Nagula
 
ATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxPraveen Nagula
 
RHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxRHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxPraveen Nagula
 
WAVES OF ECG.pptx
WAVES OF ECG.pptxWAVES OF ECG.pptx
WAVES OF ECG.pptxPraveen Nagula
 
BASICS OF ECG.pptx
BASICS OF ECG.pptxBASICS OF ECG.pptx
BASICS OF ECG.pptxPraveen Nagula
 
HISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxHISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxPraveen Nagula
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementPraveen Nagula
 
Beta blockers all are not same
Beta blockers   all are not sameBeta blockers   all are not same
Beta blockers all are not samePraveen Nagula
 
INTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIINTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIPraveen Nagula
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL Praveen Nagula
 

More from Praveen Nagula (20)

BIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptxBIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptx
 
historical aspects of hypertension.pptx
historical aspects of hypertension.pptxhistorical aspects of hypertension.pptx
historical aspects of hypertension.pptx
 
Management of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxManagement of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptx
 
ECGs in clinical practice.pptx
ECGs in clinical practice.pptxECGs in clinical practice.pptx
ECGs in clinical practice.pptx
 
PCP IN STEMI.pptx
PCP IN STEMI.pptxPCP IN STEMI.pptx
PCP IN STEMI.pptx
 
HISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSIONHISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSION
 
ATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptx
 
8.FEMI.pptx
8.FEMI.pptx8.FEMI.pptx
8.FEMI.pptx
 
RHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxRHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptx
 
WAVES OF ECG.pptx
WAVES OF ECG.pptxWAVES OF ECG.pptx
WAVES OF ECG.pptx
 
BASICS OF ECG.pptx
BASICS OF ECG.pptxBASICS OF ECG.pptx
BASICS OF ECG.pptx
 
HISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxHISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptx
 
QUIZ IV
QUIZ IVQUIZ IV
QUIZ IV
 
QUIZ .pptx
QUIZ .pptxQUIZ .pptx
QUIZ .pptx
 
QUIZ
QUIZ QUIZ
QUIZ
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes management
 
Beta blockers all are not same
Beta blockers   all are not sameBeta blockers   all are not same
Beta blockers all are not same
 
INTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIINTERESTING ECGS -- PART II
INTERESTING ECGS -- PART II
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL
 
HF update 2021
HF update 2021HF update 2021
HF update 2021
 

Recently uploaded

AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.arsicmarija21
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
Quarter 4 Peace-education.pptx Catch Up Friday
Quarter 4 Peace-education.pptx Catch Up FridayQuarter 4 Peace-education.pptx Catch Up Friday
Quarter 4 Peace-education.pptx Catch Up FridayMakMakNepo
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersSabitha Banu
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptxSherlyMaeNeri
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPCeline George
 
ROOT CAUSE ANALYSIS PowerPoint Presentation
ROOT CAUSE ANALYSIS PowerPoint PresentationROOT CAUSE ANALYSIS PowerPoint Presentation
ROOT CAUSE ANALYSIS PowerPoint PresentationAadityaSharma884161
 
call girls in Kamla Market (DELHI) 🔝 >āŧ’9953330565🔝 genuine Escort Service 🔝✔ī¸âœ”ī¸
call girls in Kamla Market (DELHI) 🔝 >āŧ’9953330565🔝 genuine Escort Service 🔝✔ī¸âœ”ī¸call girls in Kamla Market (DELHI) 🔝 >āŧ’9953330565🔝 genuine Escort Service 🔝✔ī¸âœ”ī¸
call girls in Kamla Market (DELHI) 🔝 >āŧ’9953330565🔝 genuine Escort Service 🔝✔ī¸âœ”ī¸9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxDr.Ibrahim Hassaan
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxChelloAnnAsuncion2
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Planning a health career 4th Quarter.pptx
Planning a health career 4th Quarter.pptxPlanning a health career 4th Quarter.pptx
Planning a health career 4th Quarter.pptxLigayaBacuel1
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementmkooblal
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfphamnguyenenglishnb
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 

Recently uploaded (20)

AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
Quarter 4 Peace-education.pptx Catch Up Friday
Quarter 4 Peace-education.pptx Catch Up FridayQuarter 4 Peace-education.pptx Catch Up Friday
Quarter 4 Peace-education.pptx Catch Up Friday
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginners
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptx
 
OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERP
 
ROOT CAUSE ANALYSIS PowerPoint Presentation
ROOT CAUSE ANALYSIS PowerPoint PresentationROOT CAUSE ANALYSIS PowerPoint Presentation
ROOT CAUSE ANALYSIS PowerPoint Presentation
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
call girls in Kamla Market (DELHI) 🔝 >āŧ’9953330565🔝 genuine Escort Service 🔝✔ī¸âœ”ī¸
call girls in Kamla Market (DELHI) 🔝 >āŧ’9953330565🔝 genuine Escort Service 🔝✔ī¸âœ”ī¸call girls in Kamla Market (DELHI) 🔝 >āŧ’9953330565🔝 genuine Escort Service 🔝✔ī¸âœ”ī¸
call girls in Kamla Market (DELHI) 🔝 >āŧ’9953330565🔝 genuine Escort Service 🔝✔ī¸âœ”ī¸
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptx
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Planning a health career 4th Quarter.pptx
Planning a health career 4th Quarter.pptxPlanning a health career 4th Quarter.pptx
Planning a health career 4th Quarter.pptx
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of management
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 

(Acute) Cardiac Care in COVID era

  • 1. Dr. Nagula Praveen, MD, DM Assistant Professor of Cardiology, Osmania General Hospital, Hyderabad drpraveennagula@gmail.com twitter: @kizashipraveen
  • 3.
  • 4. COronaVIrusDisease 2019 (COVID) Closely related to SARS NOVEL CORONA VIRUS
  • 5. Corona virus family ī‚§ Latin for crown, greek for garland ī‚§ Enveloped, positive sense, single stranded RNA viruses ī‚§ Peplomers or spikes on the surface ī‚§ Usually mild infections – common cold ī‚§ SARS, MERS, COVID 19 – lethal
  • 6.
  • 7.
  • 9. Why CVD to be worried in COVID times? 10.8% IN MORTALITY (3.4% USUALLY)
  • 10. ī‚§ Both have similar symptoms ī‚§ CV diseases usually are emergencies when presented to ED ī‚§ Appropriate effective timely management is important to combat the consequences if not treated (TIME IS MUSCLE, TIME IS LIFE) ī‚§ HCP and patients are at risk of COVID ī‚§ CVD and its risk factors – complications are more ī‚§ All CV Patients to be deemed to be positive for COVID and managed.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17. Issues Patient aspects ī‚§ Fear of COVID infection ī‚§ Unable to meet the expenses of admission ī‚§ Neglecting the symptoms, in background of COVID fear ī‚§ Denied access in absence of report - alarm raised ī‚§ Loss of daily wages ī‚§ Poverty
  • 18.
  • 19.
  • 20.
  • 21. HCP Aspects ī‚§ Patient to be treated on an emergency basis. ī‚§ Aerosol production can be there when doing procedures – more precautions ī‚§ Limited personnel at hand in view of social distancing. ī‚§ Lot of stress in managing the patients ī‚§ Primary PCI < Pharmacoinvasive strategy
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27. ī‚§ Donning and doffing strict precautions to be taken - 30 minutes ī‚§ Not 100% effective ( usually when not followed the steps) ī‚§ Takes ten to fifteen minutes to donn/doff ī‚§ Cumbersome after an hour ī‚§ Cant move around ī‚§ Mind is not stable ī‚§ Procedure time delayed ī‚§ Touch sensation lost
  • 28.
  • 29.
  • 30. HOSPITAL aspects ī‚§ Increased staff ī‚§ 1:1 ratio of nurse to patients ī‚§ Use of PPE Kits ī‚§ Shortage of HCP ī‚§ Decontamination ī‚§ Three times the usual expenses ī‚§ Shortage of PPE kits ī‚§ Salaries ?
  • 32. ESC guidance (not guidelines, not consensus)
  • 33. Triaging of patients is important
  • 34. STEMI
  • 35.
  • 36. ī‚§ Pharmacoinvasive strategy is better than Primary PCI. ī‚§ It is evidence based ī‚§ STREAM Trial ( fibrinolytic therapy vs PPCI) ī‚§ MORTALITY < 5% ī‚§ Increased ICH in FT ī‚§ Beneficial in Present times ī‚§ TIME OF REPERFUSION is MORE IMPORTANT THAN MODE OF REPERFUSION
  • 37.
  • 38.
  • 39. PUI = person under investigation
  • 41.
  • 44. Acute Heart Failure ī‚§ Acute myocardial injury (defined as serum hs-cTn I elevation > 99th percentile of the ULN or new abnormalities in ECG or echocardiography) occurs in 8% of COVID-19 patients. ī‚§ Ischemia, Infarction, Inflammation (Myocarditis) ī‚§ Severe COVID 22-31% ī‚§ Higher troponin values more poor prognosis ī‚§ Elevate NT BNP ī‚§ ARDS, Hypoxia, Acute Kidney Injury, hypervolemia, stress induced cardiomyopathy ī‚§ Arrhythmias
  • 45.
  • 46.
  • 48. Chronic Heart Failure ī‚§ Risk of COVID is higher ī‚§ TTE and chest CT scan can be used for further assessment. ī‚§ Attention should be given to the prevention of viral transmission to healthcare providers and contamination of the equipment; ī‚§ Patients with chronic HF should closely follow protective measures to prevent infection; ī‚§ Ambulatory stable HF patients (with no cardiac emergencies) should refrain from hospital visits; ī‚§ Guideline-directed medical therapy (including beta-blocker, ACEI, ARB or sacubitril/valsartan and mineralocorticoid receptor antagonist), should be continued in chronic HF patients, irrespective of COVID-19; ī‚§ Telemedicine should be considered whenever possible to provide medical advice and follow up of stable HF patients.
  • 49. CSA
  • 51.
  • 52.
  • 53.
  • 56.
  • 57.
  • 58.
  • 59.
  • 60.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66. NATURE CURES ITSELF COVID IS NO EXCEPTION But after every eclipse there is sunshine
  • 67.
  • 68.
  • 69.
  • 71.
  • 72.
  • 73.
  • 74.
  • 75.
  • 76.
  • 77. Take Home Message ī‚§ All patients with CVD are at high risk of severeCOVID. ī‚§ COVID mimics CVD – similar symptoms ī‚§ Type 2 MI ī‚§ All patients requiring emergency care should be deemed as COVID positive. ī‚§ Pharmacoinvasive therapy is better than Primary PCI ī‚§ Elective procedures to be avoided ī‚§ Telemedicine to be encouraged for effective bonding with patients. ī‚§ Patient should restrict to home and access hospital only in an emergency ī‚§ Follow SMS.